Kaichun Wu
Xijing Hospital · Air Force Military Medical University, China · Chief Professor of Xijing Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kaichun Wu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:21 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06995170 · Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease ProgressionXijing Hospital · recruiting · Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease · principal investigator
- N/ANCT06359808 · Clinical Characteristics of Sleep Disorders in Patients With Ulcerative ColitisXijing Hospital · recruiting · Colitis, Ulcerative, Sleep Quality, Gastrointestinal Microbiome · principal investigator
- N/ANCT06231264 · Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative ColitisXijing Hospital · recruiting · Ulcerative Colitis · principal investigator
- N/ANCT05996458 · A Population-based, Multicenter Cohort Study of Combined Screening for Gastrointestinal TumorsXijing Hospital · recruiting · Digestive Disease · study chair
- N/ANCT05895981 · Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.Xijing Hospital · recruiting · Ulcerative Colitis · study chair
- N/ANCT04179201 · Study on Clostridium Difficile Infection in Chinese Patients With Inflammatory Bowel DiseaseXijing Hospital · unknown · Inflammatory Bowel Diseases, Clostridium Infections · principal investigator
- Ph3NCT04176588 · A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative ColitisEverstar Therapeutics Limited · unknown · Moderately to Severely Active Ulcerative Colitis · principal investigator
- N/ANCT02725398 · Effect of Buscopan on Gastrointestinal Imaging Quality With Probe-based Confocal Laser EndomicroscopyXijing Hospital of Digestive Diseases · unknown · Gastrointestinal Imaging With pCLE · study director
- N/ANCT02710838 · The Feasible Research of Infrared Endoscope to Diagnose Early Gastric CancerXijing Hospital of Digestive Diseases · unknown · Early Gastric Cancer · study director
- Ph1NCT02365480 · Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in RemissionNational Cancer Institute (NCI) · completed · Ulcerative Colitis · principal investigator
- Ph1/Ph2NCT02349243 · Effect of Entacapone on Bodyweight Loss in Obese PopulationKaichun Wu · unknown · Obesity · study chair
- N/ANCT02041897 · Clinical Evaluation of EUS-FNA on Diagnosis of Pancreatic Cystic LesionsXiaoyin Zhang · unknown · Pancreatic Cyst · study chair
- N/ANCT02030769 · Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal CancerXijing Hospital of Digestive Diseases · completed · Esophageal Neoplasms · study chair
- Ph4NCT01474044 · To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG)Xinjiang Biochemical Pharmaceutical Co., Ltd. · completed · Chronic Atrophic Gastritis (CAG) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA060553 · NCI · NORTHWESTERN UNIVERSITY · PI Aleksandar Zafirovski · fiscal years 2012 to 2026Named on NCT02365480
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:21 UTC. The ranking covers the 200 most relevant of 414 PubMed records, and a shared surname and initials can bring in a namesake. All 414 on PubMed
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.N Engl J Med · 20151,116 citationsRCR 34.1
- Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction.Circulation · 2007630 citationsRCR 16.8
- Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.N Engl J Med · 2023454 citationsRCR 43.2
- Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis.Nat Med · 2021341 citationsRCR 14.7
- 328 citationsRCR 15.2
- Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.N Engl J Med · 2021325 citationsRCR 14.1
- The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.J Clin Endocrinol Metab · 2012305 citationsRCR 11.8
- Live Birth with or without Preimplantation Genetic Testing for Aneuploidy.N Engl J Med · 2021280 citationsRCR 21.8
- Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.Am J Transplant · 2012209 citationsRCR 7.3
- Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.J Clin Invest · 2014206 citationsRCR 8.0